Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results

Go back to Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results
Merck & Co. (NYSE: MRK) Delayed: 149.91 +3.04 (2.07%)
Previous Close $146.87    52 Week High $65.46 
Open $146.79    52 Week Low $47.97 
Day High $150.49    P/E 101.98 
Day Low $145.60    EPS $1.47 
Volume 3,973,386